IGC Pharma, Inc. (IGC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.22M | -1.22M | -2.09M | -1.41M | -730K | -1.32M | -996K | -1.75M | -526K | -1.59M | -1.62M | -1.47M |
| Operating CF Margin % | -385.8% | -349.43% | -1094.24% | -428.96% | -221.21% | -512.45% | -241.75% | -644.12% | -178.31% | -777.94% | -556.01% | -264.5% |
| Operating CF Growth % | -67.53% | 7.14% | -109.84% | 19.69% | -38.78% | 17.01% | 38.44% | -19.35% | 65.33% | 3.7% | 4.03% | 33.15% |
| Net Income | -2.4M | -726K | -1.82M | -1.6M | -1.2M | -1.83M | -1.72M | -2.38M | -2.88M | -5.59M | -2.45M | -2.08M |
| Depreciation & Amortization | 58K | 64K | 119K | 141K | 154K | 157K | 145K | 162K | 164K | 160K | 158K | 155K |
| Stock-Based Compensation | 1.01M | 926K | 0 | 452K | 455K | 381K | 402K | 402K | 340K | 526K | 550K | 357K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 20K | -2.15M | -325K | -24K | 154K | 0 | -14K | 0 | 181K | 3.37M | 1K | -53K |
| Working Capital Changes | 92K | 668K | -63K | -377K | -296K | -26K | 188K | 62K | 1.67M | -52K | 124K | 148K |
| Change in Receivables | -24K | 29K | 46K | -53K | 2K | -5K | -16K | 11K | -39K | 44K | 88K | -118K |
| Change in Inventory | 0 | 19K | 6K | 11K | 73K | 77K | 0 | 30K | 1.02M | -23K | 5K | 10K |
| Change in Payables | 241K | 384K | -303K | 51K | 44K | 66K | -2K | -2K | 126K | 98K | -123K | 142K |
| Cash from Investing | -170K | -228K | -374K | 580K | -142K | -104K | -65K | -131K | -323K | -61K | 72K | -5K |
| Capital Expenditures | -1K | -205K | -326K | -8K | -18K | -27K | -29K | -38K | -15K | -68K | -55K | -20K |
| CapEx % of Revenue | 0.32% | 58.57% | 170.68% | 2.44% | 5.45% | 10.51% | 7.04% | 13.97% | 5.08% | 33.33% | 18.9% | 3.6% |
| Acquisitions | 0 | 2K | -23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -169K | 0 | 0 | 588K | -124K | -77K | -36K | -93K | -308K | -19K | 127K | 15K |
| Cash from Financing | 710K | 1.26M | 3.11M | 851K | 805K | 345K | 794K | 2.51M | 667K | -1K | 2.86M | -1K |
| Debt Issued (Net) | 623K | -1K | -1K | -1K | 3K | -1K | -1K | -1K | 0 | -1K | -1K | -1K |
| Equity Issued (Net) | 87K | 1.26M | 3.11M | 852K | 805K | 346K | 795K | 2.51M | 667K | 0 | 2.86M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -693K | -205K | 651K | 49K | -65K | -1.08M | -278K | 626K | -180K | -1.65M | 1.3M | -1.47M |
| Free Cash Flow | -1.39M | -1.24M | -2.12M | -1.53M | -896K | -1.34M | -932K | -1.88M | -851K | -1.67M | -1.67M | -1.52M |
| FCF Margin % | -439.43% | -352.86% | -1109.42% | -466.16% | -271.52% | -522.96% | -226.21% | -692.28% | -288.47% | -820.59% | -574.91% | -273.15% |
| FCF Growth % | -55.47% | 8.11% | -127.36% | 18.8% | -5.29% | 19.71% | 44.29% | -24.21% | 57.28% | 3.35% | -5.35% | 35.6% |
| FCF per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 | -0.01 | -0.03 | -0.03 | -0.03 |
| FCF Conversion (FCF/Net Income) | 0.51x | 1.68x | 1.15x | 0.88x | 0.61x | 0.72x | 0.58x | 0.74x | 0.18x | 0.28x | 0.66x | 0.71x |
| Interest Paid | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |